You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Topotecan for the treatment of relapsed small-cell lung cancer

  • Technology appraisal guidance
  • Reference number: TA184
  • Published:  25 November 2009
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders Appendix A: provisional matrix of stakeholders
26 November 2012
(59.22 Kb 17 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 22 November 2012

Back to top